Results regarding Baxdrostat were presented at the ESC Congress 2025 and published in the New England Journal of Medicine.
1 report, 1 independent
Updated Aug 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Results regarding Baxdrostat were presented at the ESC Congress 2025 and published in the New England Journal of Medicine.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
European Society of Cardiology
non-profit knowledge-based professional association
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- Business WireBaxdrostat demonstrated statistically significant and clinically meaningful reduction in systolic blood pressure in patients with hard-to-control hypertension in the BaxHTN Phase III trial Baxdrosta